Govt seeks comments on residual shelf-life requirement for imported drugs. (Photo | IANS)
India

Centre seeks public comments on draft amendment to rationalise residual shelf-life norms for imported drugs

The Centre proposes to revise the existing requirement of a minimum residual shelf life of more than 60 per cent for imported drugs to a minimum residual shelf life of 12 months at the time of import.

TNIE online desk

The Union Ministry of Health and Family Welfare has issued a draft notification proposing changes to Rule 31 of the Drugs Rules, 1945, aimed at rationalising residual shelf-life requirements for imported medicines and improving the ease of doing business in the pharmaceutical sector.

According to the press release by the Ministry of Health and Family Welfare, the draft amendment, published for public consultation vide Gazette Notification G S R 505 (E) dated 22nd June 2026, proposes to revise the existing requirement of a minimum residual shelf life of more than 60 per cent for imported drugs to a minimum residual shelf life of 12 months at the time of import.

However, in view of their specialised nature and public health considerations, the existing requirement of a minimum residual shelf life of more than 60 per cent shall continue to apply to biological products and radiopharmaceuticals.

The proposed amendment seeks to facilitate greater efficiency in the pharmaceutical supply chain while maintaining the availability of quality medicines for patients. By ensuring that imported drugs have a minimum remaining shelf life of twelve months upon entry into the country, the proposal provides sufficient time for distribution and consumption before expiry, thereby ensuring that patients continue to receive medicines with adequate usable shelf life.

The amendment is also expected to improve utilisation of pharmaceutical inventories across the supply chain by reducing avoidable wastage of medicines arising from restrictive residual shelf-life requirements. This, in turn, is expected to optimise supply management, reduce costs, and strengthen the availability of essential medicines in the country, the release stated.

The Ministry has clarified that the proposed amendment pertains solely to the residual shelf-life requirement applicable at the time of import of drugs. The proposal does not alter any other regulatory requirements relating to the quality, safety or efficacy of medicines under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945.

The Ministry has invited objections and suggestions from all stakeholders on the draft notification.

(With inputs from ANI)

‘You cannot fight politically, so it is a bulldozer, sometimes a false case’: Abhishek Banerjee

Supriya Sule rules out NCP merger, says talks ended with Ajit Pawar’s untimely demise

Microsoft restores all services after global outage, apologises and cites network upgrade issue

'CM Shivakumar's Mekedatu remarks painful': Congress' Manickam Tagore urges CM Vijay to pursue legal measures

Rahul Gandhi launches Telangana gig workers’ welfare scheme, says law guarantees access to work data